LeMaitre Vascular Q3 sales up 16% to $54.8M, EPS $0.49 (+46%), raises full-year guidance

LEMAITRE VASCULAR INC

2024-Q3 EPS reported $1.45 revenue$164,146,000

Q3 sales $54.8M (+16% organic); diluted EPS $0.49, +46% YoY.
Gross margin 67.8% (+280 bps) on price increases and manufacturing efficiencies.
Full-year guidance raised: sales $219-221M, op margin 24%, EPS $1.91-1.96.
Quarterly dividend of $0.16/share declared, payable Dec 5 to holders of record Nov 21.
Cash increased $10.8M sequentially to $123.9M; $50M share repurchase program ongoing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.